Then (1962), The Doors of Perception
Psilocybin for End-of-Life Anxiety: Huxley's Island Made Clinical
Huxley's 1962 novel Island portrayed moksha-medicine being given to the dying as a sacrament, not to cure but to transform the experience of dying. He developed this argument from his wife Laura's account of giving him LSD on his deathbed (November 22, 1963). His claim was not clinical; it was philosophical and spiritual: psychedelics could make death accessible rather than terrifying.
confirmed
Psilocybin for end-of-life anxiety produces the largest effect sizes ever recorded in psychopharmacology for this indication. Griffiths et al. (Journal of Psychopharmacology, 2016, n=51): Hedges' g=1.3 for depression and 0.82 for anxiety at 6-month follow-up. Ross et al. (Journal of Psychopharmacology, 2016, n=29): 83% of participants showed significant reduction in anxiety. A 2020 meta-analysis (Agin-Liebes et al.) confirmed sustained effects. The Australian TGA approved psilocybin for this indication in February 2023, making it the world's first regulated psychedelic-assisted therapy. Huxley's Island described exactly this: a compassionate, guided, sacramental use of psychedelics for the dying. The clinical evidence confirms it works.
Sources
- Griffiths et al., J Psychopharmacology (2016)
- Ross et al., J Psychopharmacology (2016)
- TGA Schedule 8 Approval (February 2023)